Company intelligence / Profile preview

CareLigo

Ownership: Private
Development stage: Commercial

Overview

CareLigo has developed OPTILOGG, a clinically validated home-based digital solution that empowers heart failure patients to manage their condition. The system includes a smart scale and tablet interface to monitor weight changes and medication adherence. Clinical research—including two randomized controlled trials—demonstrates that OPTILOGG improves patient engagement and reduces healthcare burden[1][2].

Therapeutic areas: OtherCardiovascular
Modalities: DeviceSoftwareNon-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on CareLigo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareLigo.

Explore the full profile